Deerfield, IL - Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush ...

Review the side-effects of Preservative-Free Heparin Lock Flush Solution as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

The FDA has now concluded that there is sufficient capacity on the part of other suppliers that Baxter's recall will not jeopardize access to this drug, and has told Baxter that the company can now ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

The U.S. Pharmacopeial Convention (USP) has revised its current standards on heparin labeling requirements to address safety concerns about the expression of drug strength. The labeling sections for ...

February 9, 2007 — The US Food and Drug Administration (FDA) and Baxter Healthcare Corp have warned healthcare professionals via letter regarding the potential for life-threatening substitution errors ...

The alternative text for this image may have been generated using AI. Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides ...